Eleusis SPAC

eleusis Eleusis at-a-glance Dedicated to transforming psychedelics into medicines for living WE ARE DEVELOPING A 2nd generation investigational psilocybin-based drug candidate for Major Depressive Disorder (MDD) and a discovery platform for exploration beyond psychiatry ■ A care delivery management company to help facilitate seamless "in-network" integration with existing US healthcare infrastructure ALTUS

View entire presentation